Search the Newsreel

Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS

Dimensional Fund Advisors LP reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.2% in the first quarter, though it still holds 546,626 shares valued at $8.67 million. Institutional investors collectively own 69.05% of the stock. Analysts generally maintain a "Moderate Buy" rating for OrthoPediatrics, …

Orthopediatrics Corp Q2 2026: Revenue $70.5M, EPS $(0.30) — 10-Q Summary

Orthopediatrics Corp (KIDS) reported its Q2 2026 financial results, with revenue increasing to $70.5 million from $61.1 million year-over-year. The company posted a net loss of $7.16 million and diluted EPS of $(0.30), largely consistent with the previous year. Key growth drivers included Trauma …

OrthoPediatrics Corp. Stock 12‑Month Price Target Raised to $26.67, Implies 28% Upside

Analysts have raised the 12-month average price target for OrthoPediatrics Corp. stock from $25 to $26.67, with individual forecasts ranging from $22 to $35 per share. This new target implies a potential upside of approximately 28% from the Aug. 4 closing price. The consensus …

ORTHOPEDIATRICS CORP : NEEDHAM RAISES TARGET PRICE TO $35 FROM $30

Needham has increased its target price for ORTHOPEDIATRICS CORP (KIDS.O) to $35 from the previous $30. This adjustment indicates a more optimistic outlook by the analyst firm regarding the company's future stock performance. The report was issued by Reuters.

OrthoPediatrics (Nasdaq: KIDS) lifts 2026 guidance after strong Q2 growth

OrthoPediatrics reported record Q2 2026 net revenue of $70.5 million, marking a 15% increase year-over-year, primarily driven by strong growth in Trauma and Deformity products and international sales. The company also achieved a record adjusted EBITDA of $6.8 million and significantly improved free cash …

OrthoPediatrics: Q2 Earnings Snapshot

OrthoPediatrics Corp. (KIDS) reported a Q2 loss of $7.2 million, or 30 cents per share, which adjusted to 26 cents per share. The medical device maker posted revenue of $29.5 million for the quarter and expects full-year revenue to be between $125 million and …

OrthoPediatrics (NASDAQ: KIDS) eyes $265M–$269M 2026 revenue, cash breakeven

OrthoPediatrics Corp. (NASDAQ: KIDS) is projecting 2026 revenue between $265 million and $269 million, alongside an Adjusted EBITDA of approximately $25 million and roughly breakeven free cash flow. This outlook is detailed in an investor update that also highlights the company's focus on the …

Nearly 46,000 children helped as OrthoPediatrics revenue hits $70.5M

OrthoPediatrics (Nasdaq: KIDS) reported record Q2 2026 revenue of $70.5 million, a 15% year-over-year increase, driven by strong growth in U.S. and international markets, particularly in its Trauma & Deformity segment. The company helped nearly 46,000 children and achieved a record adjusted EBITDA of …

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

OrthoPediatrics Corp. announced strong financial results for the second quarter of 2026, with record total revenue of $70.5 million, marking a 15% year-over-year increase, and record adjusted EBITDA of $6.8 million. The company helped nearly 46,000 children and significantly reduced free cash flow usage. …

OrthoPediatrics (NASDAQ:KIDS) Issues Earnings Results

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

The Technical Signals Behind (KIDS) That Institutions Follow

This article from Stock Traders Daily discusses the technical signals for Orthopediatrics Corp. (NASDAQ: KIDS) that institutions follow. It highlights strong near-term sentiment with neutral mid and long-term outlooks, noting compelling upside potential due to a lack of resistance levels above the current price. …

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrowing Loss Beats Estimates, Stock Edges Higher

OrthoPediatrics Number of Employees 2026 | Employee Count & Headcount Data

OrthoPediatrics Corp. (NASDAQ: KIDS) has approximately 606 employees worldwide as of March 2026, marking a 13.6% growth from 2023. The company is actively hiring, with 45 active job postings in 2026, an 11.8% increase from 2025. The workforce is primarily concentrated in North America, …

OrthoPediatrics to Join Canaccord Conference Aug. 12 | KIDS Stock News

OrthoPediatrics (Nasdaq: KIDS) announced that its President & CEO, Dave Bailey, and COO & CFO, Fred Hite, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026, at 9:00 a.m. ET. An audio webcast of the …

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

OrthoPediatrics Corp. (Nasdaq: KIDS) announced its President & CEO, Dave Bailey, and COO & CFO, Fred Hite, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 9:00 am ET. An audio webcast and …

Medical device manufacturer gets a new backbone after global takeover

Chesterfield-based medical device manufacturer SpineCorporation has been acquired by the US healthcare company OrthoPediatrics Corp. The acquisition, supported by Hawsons Corporate Finance and Knights Solicitors, will expand OrthoPediatrics' presence in the specialist healthcare market. This cross-border deal marks a significant milestone for SpineCorporation, with …

OrthoPediatrics Corp. Revenue Breakdown – SWB:2X7

OrthoPediatrics Corp. (SWB:2X7) generated €201.23 million in revenue last year, with its Trauma and Deformity segment contributing the most at €141.59 million. The majority of the company's revenue, €158.71 million, originated from the United States. These figures highlight the company's key revenue drivers and …

KIDS|OrthoPediatrics Corp|Price:18.840|Chg%:+0.120

OrthoPediatrics Corp (KIDS) has strong fundamentals and high growth potential, with its revenue averaging 58.91% year-on-year growth over the past three years. The stock is considered fairly valued and has a high institutional ownership, with multiple analysts rating it as a "Buy" with a …

OrthoPediatrics sets Aug. 4 date for second-quarter results

OrthoPediatrics Corp. (Nasdaq: KIDS) announced it will release its second-quarter 2026 financial results on Tuesday, August 4, 2026, after market close. The company will host a conference call on the same day at 4:30 p.m. ET to discuss these results, with a live and …

OrthoPediatrics to report Q2 2026 financial results on August 4

OrthoPediatrics Corp. is scheduled to release its financial results for the second quarter of 2026 on August 4, 2026, after the market closes. The company, which specializes in pediatric orthopedics, will hold a conference call on the same day at 4:30 p.m. ET to …

Precision Trading with Orthopediatrics Corp. (KIDS) Risk Zones

This article analyzes Orthopediatrics Corp. (KIDS) with a focus on precision trading, highlighting a weak near-term sentiment that could lead to bearish positioning. It outlines three distinct AI-generated trading strategies including position, momentum breakout, and risk hedging, tailored for different risk profiles. The analysis …

KIDS Q1 2026 Earnings: EPS Surprise but Stock Declines on Revenue Omission - One-Time Gain Impact

KIDS5867370 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the OrthoPediatrics Corp. bond KIDS5867370, detailing its interest rate and payment schedule. The bond has a current coupon rate of 4.75%, with the next payment anticipated on August 17, 2026. It highlights the importance of understanding bond …

KIDS5867370 Bond Profile — Key Metrics

This article provides a bond profile for OrthoPediatrics Corp. 4.75% 15-FEB-2030 (KIDS5867370). It details key metrics such as issue date, maturity date, coupon rate, and issuer information. The bond has an outstanding amount of 0.00 USD and a face value of 1,000.00 USD.

OrthoPediatrics Corp. (NASDAQ: KIDS) holders disclose 3.2% ownership stake

Integrated Core Strategies (US) LLC and related Millennium entities, including Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, have reported a beneficial ownership stake of 3.2% in OrthoPediatrics Corp. (NASDAQ: KIDS) through a Schedule 13G/A filing. Integrated Core Strategies holds 811,042 …

Technical Analysis of Kidsland International Holdings Limited (HKEX:2122)